US Bancorp’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $22K | Buy |
2,676
+179
| +7% | +$1.47K | ﹤0.01% | 3135 |
|
2025
Q1 | $17.9K | Buy |
2,497
+2,367
| +1,821% | +$16.9K | ﹤0.01% | 3212 |
|
2024
Q4 | $1.01K | Sell |
130
-2,352
| -95% | -$18.2K | ﹤0.01% | 3948 |
|
2024
Q3 | $26K | Sell |
2,482
-1,789
| -42% | -$18.8K | ﹤0.01% | 3028 |
|
2024
Q2 | $50K | Sell |
4,271
-2,151
| -33% | -$25.2K | ﹤0.01% | 2675 |
|
2024
Q1 | $135K | Sell |
6,422
-7,409
| -54% | -$156K | ﹤0.01% | 2209 |
|
2023
Q4 | $248K | Buy |
13,831
+13,586
| +5,545% | +$244K | ﹤0.01% | 1902 |
|
2023
Q3 | $4.03K | Hold |
245
| – | – | ﹤0.01% | 3484 |
|
2023
Q2 | $4.9K | Buy |
245
+37
| +18% | +$740 | ﹤0.01% | 3455 |
|
2023
Q1 | $3.93K | Sell |
208
-23
| -10% | -$435 | ﹤0.01% | 3585 |
|
2022
Q4 | $5.24K | Sell |
231
-62
| -21% | -$1.41K | ﹤0.01% | 3480 |
|
2022
Q3 | $8K | Sell |
293
-214
| -42% | -$5.84K | ﹤0.01% | 3438 |
|
2022
Q2 | $13K | Sell |
507
-419
| -45% | -$10.7K | ﹤0.01% | 3265 |
|
2022
Q1 | $31K | Buy |
926
+142
| +18% | +$4.75K | ﹤0.01% | 2830 |
|
2021
Q4 | $26K | Buy |
784
+154
| +24% | +$5.11K | ﹤0.01% | 2963 |
|
2021
Q3 | $26K | Buy |
630
+227
| +56% | +$9.37K | ﹤0.01% | 2979 |
|
2021
Q2 | $16K | Buy |
403
+218
| +118% | +$8.66K | ﹤0.01% | 3232 |
|
2021
Q1 | $6K | Hold |
185
| – | – | ﹤0.01% | 3439 |
|
2020
Q4 | $8K | Buy |
+185
| New | +$8K | ﹤0.01% | 3245 |
|
2020
Q1 | – | Sell |
-39
| Closed | -$2K | – | 3692 |
|
2019
Q4 | $2K | Hold |
39
| – | – | ﹤0.01% | 3439 |
|
2019
Q3 | $1K | Sell |
39
-15
| -28% | -$385 | ﹤0.01% | 3512 |
|
2019
Q2 | $3K | Hold |
54
| – | – | ﹤0.01% | 3397 |
|
2019
Q1 | $3K | Hold |
54
| – | – | ﹤0.01% | 3360 |
|
2018
Q4 | $2K | Buy |
54
+18
| +50% | +$667 | ﹤0.01% | 3427 |
|
2018
Q3 | $3K | Buy |
+36
| New | +$3K | ﹤0.01% | 3434 |
|